🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Momentum building...

Exercise may augment our immune response with impact on tumour regression. Time for surgeons to prescribe exercise as part of our cancer treatment pathway? PERIOP-OG will provide more evidence.

Association between peri-operative morbidity and compliance with ERAS in colorectal surgery - logical that same may be true after oesophagectomy .... but ERAS just one of the factors at play here #prehabilitation #nutrition #minimallyinvasiveoesophagectomy

Laparoscopic D2 gastrectomy can be every bit as radical as open surgery with the benefit of enhanced patient recovery. Time to move the debate on? Laparoscopic vs Open Distal Gastrectomy and Disease-Free Survival in Locally Advanced Gastric Cancer ja.ma/31Ib8qw

FFCD9901 showed that despite best staging with EUS, PET and CT 26% of stage I and II patient are upstaged after primary surgery - What we do with cT2NO disease remains problematic - Should we overtreat circa 75% of patients to avoid undertreating 25%? ....ncbi.nlm.nih.gov/pubmed/24982463

Just published in Diseases of the Esophagus our systematic review which has lead to PERIOP-OG #prehabilatation #ERAS Perioperative prehabilitation and rehabilitation in esophagogastric malignancies: a systematic review academic.oup.com/dote/advance-a…

A slick demo which has been well worked out by Frans van Workum and Radbound UMC team. Intrathoracic placement of anvil and use of circular stapler not easy - especially for those of us who do this prone or semi prone. Really good demo.

Thanks to @clairec10619907 and all the #ERAS and #prehabilitation team.#educateoperaterecover. ERAS® Society @ERASsocietyUK @LollipopDayIE

iamabariatricpatient Neil Floch MD Abolish stigma against obesity and bariatric surgery. Please RT : authors.elsevier.com/a/1ZKro6CXNFdt…

vimeo.com/user14584269/r… Delighted to launch #OesophagealCancer pathway video in Beaumont Hospital which is a super resource for patients and families. Thanks to [email protected] for all his hard work! Irish Cancer Society #minimallyinvasiveoesophagectomy #ERAS

Check out the Program Highlights of the 2019 Annual Meeting of the European Society for Diseases of the Esophagus (ESDE) in #Athens: bit.ly/2lLg8tM

More evidence that both surgical quality and an uncomplicated recovery impacts on our patients' survival. #lymphadenectomy #ERAS #nutrition #prehabilitation #minimallyinvasivesurgery ... they all play their role. #marginalgains insights.ovid.com/pubmed?pmid=31…

Let's all share Guy Verhofstadt's relief that Prime Minister Johnson didn't end up dying in a ditch....🤣

Getting patients #fitforsurgery and improving quality of life. Halfway point for our PERIOP-OG trial and recruitment should conclude July 2020.#prehabilitation #ERAS #esophagealcancer #gastriccancer NCCP Irish Cancer Society @LollipopDayIE @paulcullenit

Don't miss the Diseases of the Esophagus #EditorsChoice systematic review on "Perioperative prehabilitation and rehabilitation in esophagogastric malignancies". Read this and other great research on the #DOTE website OUP Medicine bit.ly/2ONYul9

Do you use stents to relieve dysphagia during neoadjuvant treatment? Maybe not such a good idea.... Use of esophageal stents to relieve dysphagia during neoadjuvant therapy prior to esophageal resection: a systematic review academic.oup.com/dote/advance-a…

Mount Errigal, Donegal at Winter time! 😮🍀

Long term follow up of the MIRO trial has been just published. We have a thought for pr christophe mariette who conducted this important study. #fregat CHU de Lille

Check out this presentation taking place at SSO 2020! 94: Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer Following Neoadjuvant Chemoradiation Therapy: First Results of the CheckMate 577 Study Link: cdmcd.co/b43MY9

Interview with Carel Le Roux on BBC Radio 5: #SAXENDA All You Need to Know. #ObesityIsNotYourFault itsnotyourfault.ie/home/interview…